Skip to content
  • Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Policies
      • Terms of Use
      • FCOI
      • Privacy Policy
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
    • News archive
Homepage
Open navigation
  • Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Policies
      • Terms of Use
      • FCOI
      • Privacy Policy
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
    • News archive

Posts in: press clippings

Tomorrow Today show: AI, enzymes and the future of medicine
heltzennutraceuticalsmedicinepress clippingsvideopodcastNCT
Tomorrow Today show: AI, enzymes and the future of medicineNovember 3, 2026
WTR fireside chat & report: CEO Discusses the Road to Commercialization
heltzennutraceuticalspress clippingsvideoNCT
WTR fireside chat & report: CEO Discusses the Road to CommercializationOctober 29, 2026
Benzinga: The Next Industrial Revolution May Come From Biology
investorpress clippings
Benzinga: The Next Industrial Revolution May Come From BiologyOctober 28, 2026
Damien Perriman on Balancing the Future podcast
press clippingspodcastperrimanNCT
Balancing the Future podcast: Cell-free bioengineering - the new chemical manufacturing frontierOctober 20, 2026
Mashable: AI is accelerating Drug Discovery. Can manufacturing keep up?
investorpress clippingsNCT
Mashable: AI is accelerating Drug Discovery. Can manufacturing keep up?October 19, 2026
Pix11 "Top Leaders" featuring EXOZ CEO, Heltzen
heltzeninvestorpress clippingsvideoNCT
Pix11 News: Reinventing How Medicine Is MadeOctober 8, 2026
Slack Capital: eXoZymes’ Path to Computational Biomanufacturing
investorpress clippings
Slack Capital: eXoZymes’ Path to Computational BiomanufacturingOctober 7, 2026
Heltzen on Grow Everything podcast, episode #201
heltzennutraceuticalspress clippingsvideoNCT
Grow Everything podcast: Out of Cell Experience - Heltzen Drives Pure ChemistryOctober 2, 2026
WTR: INITIATION OF COVERAGE REPORT
investorpress clippings
WTR: Converting Cell-Free Science into a Scalable and Repeatable Commercial OpportunityOctober 1, 2026
Globe and Mail: eXoZymes Sets Date for 2026 Shareholders Meeting
investorpress clippings
The Globe and Mail: eXoZymes Sets Date for 2026 Shareholders MeetingSeptember 19, 2026
Previous page
Page 1 of 7
Next page

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

logo mark